pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3655 |
Genomic Coordinates | chr5: 140647844 - 140647926 |
Description | Homo sapiens miR-3655 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3655 | ||||||||||||||||||||||||||||||
Sequence | 1| GCUUGUCGCUGCGGUGUUGCU |21 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | 454 | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | HARBI1 | ||||||||||||||||||||
Synonyms | C11orf77 | ||||||||||||||||||||
Description | harbinger transposase derived 1 | ||||||||||||||||||||
Transcript | NM_173811 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on HARBI1 | |||||||||||||||||||||
3'UTR of HARBI1 (miRNA target sites are highlighted) |
>HARBI1|NM_173811|3'UTR 1 TGTAGAAGGTGGAGAGGAGGGATACTTCCCAGGAGTTGTGACAGACTTTCCTCCTCATCACCTTTTACACAGTTCCATCA 81 TCTAGCATGACTGAGTATACAGATACTTGTCATAAACTGACATTTAATATGTGTGTTTTGGTAAGGTTGGGGCTATGCCA 161 GAATATCTTGATTCATTTGCATATGCATTAATTAAACTGAAACCAAGACAGCGGCTCCCTACTAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084078. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084079. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084078 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000326737.3 | 3UTR | ACAAGACCAGCCUGGCCAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1084079 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000326737.3 | 3UTR | AAGACAAGACCAGCCUGGCCAACAUGGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
32 hsa-miR-3655 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT446335 | ATP5C1 | ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 | 2 | 2 | ||||||||
MIRT476874 | FEM1B | fem-1 homolog B | 2 | 2 | ||||||||
MIRT500976 | SPPL2A | signal peptide peptidase like 2A | 2 | 4 | ||||||||
MIRT558681 | CNEP1R1 | CTD nuclear envelope phosphatase 1 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT617898 | PTCHD3 | patched domain containing 3 | 2 | 2 | ||||||||
MIRT620111 | HARBI1 | harbinger transposase derived 1 | 2 | 2 | ||||||||
MIRT620647 | CXCL5 | C-X-C motif chemokine ligand 5 | 2 | 2 | ||||||||
MIRT630797 | FAM46A | family with sequence similarity 46 member A | 2 | 2 | ||||||||
MIRT632226 | WDR37 | WD repeat domain 37 | 2 | 2 | ||||||||
MIRT638561 | KCNJ10 | potassium voltage-gated channel subfamily J member 10 | 2 | 2 | ||||||||
MIRT639110 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | 2 | 2 | ||||||||
MIRT640352 | C1orf210 | chromosome 1 open reading frame 210 | 2 | 2 | ||||||||
MIRT642520 | CNTROB | centrobin, centriole duplication and spindle assembly protein | 2 | 2 | ||||||||
MIRT642646 | PTGR2 | prostaglandin reductase 2 | 2 | 2 | ||||||||
MIRT643505 | ZNF28 | zinc finger protein 28 | 2 | 2 | ||||||||
MIRT645690 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT645936 | HIPK1 | homeodomain interacting protein kinase 1 | 2 | 2 | ||||||||
MIRT647643 | FAIM2 | Fas apoptotic inhibitory molecule 2 | 2 | 2 | ||||||||
MIRT648513 | PIGG | phosphatidylinositol glycan anchor biosynthesis class G | 2 | 2 | ||||||||
MIRT649163 | IQSEC1 | IQ motif and Sec7 domain 1 | 2 | 2 | ||||||||
MIRT651442 | XKR4 | XK related 4 | 2 | 2 | ||||||||
MIRT654151 | RPAP2 | RNA polymerase II associated protein 2 | 2 | 2 | ||||||||
MIRT657780 | GLIS3 | GLIS family zinc finger 3 | 2 | 2 | ||||||||
MIRT661242 | ARL17B | ADP ribosylation factor like GTPase 17B | 2 | 2 | ||||||||
MIRT664082 | METTL2B | methyltransferase like 2B | 2 | 2 | ||||||||
MIRT671672 | HEYL | hes related family bHLH transcription factor with YRPW motif-like | 2 | 2 | ||||||||
MIRT672199 | F2 | coagulation factor II, thrombin | 2 | 2 | ||||||||
MIRT693599 | SLC39A1 | solute carrier family 39 member 1 | 2 | 2 | ||||||||
MIRT714567 | GALNT10 | polypeptide N-acetylgalactosaminyltransferase 10 | 2 | 2 | ||||||||
MIRT721589 | LRRC2 | leucine rich repeat containing 2 | 2 | 2 | ||||||||
MIRT722888 | MOB3A | MOB kinase activator 3A | 2 | 2 | ||||||||
MIRT724762 | PSG4 | pregnancy specific beta-1-glycoprotein 4 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|